IVF denied as experimental or investigational by Humana?

Humana's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Labeled IVF Experimental — and Why That Classification Is Contestable

A denial on experimental or investigational grounds means Humana has determined that the specific IVF procedure, protocol, or an add-on technique used in your case does not yet meet its standard of proven clinical effectiveness. For straightforward IVF, this classification is unusual and often overturned, because IVF has decades of published outcomes data and is recognized as standard of care by major reproductive medicine organizations. Where this denial more commonly arises is when an add-on procedure is bundled into the IVF request — for example, certain preimplantation genetic testing protocols, adjuvant treatments, or laboratory techniques that Humana's medical policy has not yet reviewed and approved.

## Why This Denial Is Appealable

The standard Humana uses to evaluate experimental status is typically set out in its own medical policy — it often references whether the technology has been assessed by an independent evidence-review body, whether it appears in the coverage policies of other major insurers, or whether it is recognized by a named clinical guideline organization. Your appeal should engage each prong of that standard directly. The American Society for Reproductive Medicine (ASRM) and, where relevant, the Preimplantation Genetic Diagnosis International Society (PGDIS) publish position statements and practice guidelines that may address the specific technique at issue. Your physician should cite the applicable guideline organization and explain why the procedure meets accepted clinical standards for your diagnosis.

## Your Federal Appeal Rights

• Internal appeal — file within 180 days of the denial. Humana must respond within 30 days (pre-service) or 60 days (post-service).
• External review (ACA §2719) — experimental/investigational denials are specifically eligible for external review under federal law. Request IRO review within four months of the final internal denial. The IRO decision is binding.
• Expedited review — if your physician certifies urgent need, a 72-hour determination is available.
• ERISA §503 — employer self-funded plans carry full-and-fair review rights and federal court access.

## What to Gather

• Humana's experimental/investigational policy — obtain the specific policy Humana applied and identify its evaluation criteria.
• Physician support letter — your reproductive endocrinologist should explain the clinical basis for each component of your IVF protocol, identify the guideline organizations that recognize it as standard practice, and address Humana's experimental criteria point by point.
• Diagnosis and clinical history — chart documentation showing why this specific protocol was selected for your individual diagnosis, not as a research intervention but as a clinically indicated treatment.
• ASRM or relevant society guidance — your physician should reference the applicable guideline organization; include practice bulletins or committee opinions if your physician has copies.

## Criteria-Mapping Structure

Pull Humana's experimental/investigational coverage criteria verbatim. For each criterion, provide the specific chart fact, physician statement, or guideline-organization reference that demonstrates the procedure meets that standard. If Humana's policy requires peer-reviewed literature support, your physician's letter should reference that literature by type and organization — your physician can cite it; your appeal letter should note that the support exists and that your physician's letter addresses it.